Publications
By Year
Now showing items 21-40 of 5596 records
First in Human Feasibility Study of an Insulin Patch Pump Combined With CGM-Insulin Delivery Cannula.
Hannah Cunningham; Hanna Jones; Steve Flint; Emma Netzer; Ralph Dutt-Ballerstadt; Peter Eckenberg; Varuni Obeyesekere; Katrin Ellen Brown; Catriona Sims; Solomon Reid; Huan-Ping Wu; Thomas Seidl; Marcel Both; Adrian Auderset; Daniel Eymann; Tamara Lodico; Michael Schoemaker; Yee Wen Kong; David Norman O'Neal
JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY - 09 Apr 2026
Combining a patch pump (PP) with a single-insertion glucose-sensing cannula (continuous glucose monitor with an insulin set [CGM-IS]) may reduce user burden compared with tethered insulin pumps or multiple daily injections. We aimed to determine feasibility of a combined device. This feasibility study evaluated a PP with a CGM-IS (PP-CGM-IS) with manual bolus insulin dosing in T1D adults with i...
The nationwide prevalence of anaemia and the associated factors in the general adult population in Malaysia.
Kim Sui Wan; Nor'ain Ab Wahab; Yee Mang Chan; Wan Fei Khaw; Nur Hamizah Nasaruddin; Siti Hafizah Zulkiply; Kah Kian Chong; Ping Foo Wong; Lee-Ling Lim; Noor Ani Ahmad
BMC PUBLIC HEALTH - 07 Apr 2026
Author Correction: Consuming a modified Mediterranean ketogenic diet reverses the peripheral lipid signature of Alzheimer's disease in humans.
Bryan J Neth; Kevin Huynh; Corey Giles; Tingting Wang; Natalie A Mellett; Thy Duong; Colette Blach; Leyla Schimmel; Thomas C Register; Kaj Blennow; Henrik Zetterberg; Richa Batra; Annalise Schweickart; Amanda Hazel Dilmore; Cameron Martino; Matthias Arnold; Jan Krumsiek; Xianlin Han; Pieter C Dorrestein; Rob Knight; Peter J Meikle; Suzanne Craft; Rima Kaddurah-Daouk
COMMUNICATIONS MEDICINE - 06 Apr 2026
Plasma lipid trajectories improve prediction of future Alzheimer's disease.
Haotian Zou; Tingting Wang; Kevin Huynh; Peter J Meikle; Rima Kaddurah-Daouk; Sheng Luo; ;
JOURNAL OF ALZHEIMER'S DISEASE : JAD - 06 Apr 2026
BackgroundEarly identification of individuals at elevated risk for Alzheimer's disease (AD) is critical for prevention. Blood-based biomarkers offer scalable alternatives to cerebrospinal fluid and imaging, but the prognostic value of longitudinal plasma lipid trajectories remains unclear.ObjectiveTo evaluate whether multi-year plasma lipid trajectories improve prediction of AD conversion beyon...
Deprescribing in Older People: A Clinical Practice Guideline Summary.
Hui Wen Quek; Xisco Reus Perello; Kenneth Lee; Atinuke Abraham; Leon A Adams; Osvaldo P Almeida; Hend Almutairi; Bree Armstrong; Leanne Boase; Juanita Breen; Lauren J Brown; Gillian E Caughey; Lewis W Chan; Roger Chen; Edward Chew; Antony Clark; Tracy Comans; Deirdre Criddle; Pēteris Dārziņš; Paresh Dawda; Jenny A Doust; Sue Edwards; Jennifer Gowan; Kerryn Hart; Deborah Hawthorne; Andrew Heredia; Anne-Marie Hill; Jesse Jansen; Lisa Kalisch Ellett; Helen Keen; Erin A Kelty; Ngaire M Kerse; Estie Kruger; Susan E Kurrle; Howard Lance; Adam Livori; Rebecca Livori; Dina C LoGiudice; Arduino A Mangoni; Anthony Marinucci; Nilufeur McKay; Allison M Mckendrick; Andrew J McLachlan; Treasure M McGuire; Stewart Mearns; Mark Morgan; Saba Nabi; Vasi Naganathan; Elaine Newman; Christopher A C M Ng; Maz Osborne; Ray Parkin; Kevan R Polkinghorne; Constance Dimity Pond; Kathleen Potter; Debbie Rigby; Debra Rowett; Amina Schipp; Veronika Seda; Jessica Seeto; Sepehr Shakib; Angela Shiu; Andrew C Stafford; Irene J Tan; Marc Tennant; Leanne Teoh; Stephen Tucker; John D G Watson; Donna Wellins; Tim Whitmore; Christopher Etherton-Beer; Amy T Page
THE MEDICAL JOURNAL OF AUSTRALIA - 01 Apr 2026
Older people face higher risks of medicine-related harm due to polypharmacy and the use of potentially inappropriate medicines. Current treatment guidelines rarely specify when to stop medicines, leading to medicines often being continued indefinitely without a clear deprescribing plan. While deprescribing guidelines exist for some medicine classes, limited guidance is a major barrier to depres...
sAlpha-7 nicotinic acetylcholine receptor: targeting the interplay between inflammation, renin-angiotensin aldosterone system, and nervous system for the novel treatment of heart failure.
Jordan Swiderski; Laura Kate Gadanec; Stephen Hearth; Benjamin Darcy Rowlands; Andrew James Murphy; Vasso Apostolopoulos; Anthony Zulli
FRONTIERS IN PHARMACOLOGY - 01 Jan 2026
The incidence and prevalence of heart failure (HF) with preserved ejection fraction (HFpEF) continue to rise, yet evidence-based therapy remains limited. Due to the complexity of HFpEF pathology, traditional HF medication has shown inconsistent efficacy in improving clinical outcomes and reducing morbidity. Therefore, highlighting the urgent need for novel interventions. The αlpha-7 nicotinic a...
Comparing dementia prevalence in Australians with and without diabetes across sociodemographic groups: Findings from the 2021 national census.
Kanika Mehta; Joanna Y Gong; Jovan A Santoso; Agus Salim; Blossom C M Stephan; Kaarin J Anstey; Jonathan E Shaw; Dianna J Magliano
JOURNAL OF ALZHEIMER'S DISEASE : JAD - 17 Apr 2026
BackgroundDiabetes is a recognized risk factor for dementia, but its impact on dementia burden across sociodemographic groups in Australia is not well characterized.ObjectiveTo compare prevalence of dementia among Australians with and without diabetes and examine variation across key sociodemographic factors.MethodsWe conducted a cross-sectional analysis of the 2021 Australian national census a...
Uncovering shared and tissue-specific molecular adaptations to intermittent fasting in liver, brain, and muscle.
Yibo Fan; Senuri De Silva; Nishat I Tabassum; Xiangyuan Peng; Vernise J T Lim; Xiangru Cheng; Keshava K Datta; Rohan Lowe; Terrance G Johns; Mark P Mattson; Suresh Mathivanan; Christopher G Sobey; Eitan Okun; Yong U Liu; Guobing Chen; Mitchell Kim Peng Lai; Dong-Gyu Jo; Jayantha Gunaratne; Thiruma V Arumugam
ELIFE - 17 Apr 2026
Intermittent fasting (IF) has emerged as a powerful dietary intervention with profound metabolic benefits, yet the tissue-specific molecular mechanisms underlying these effects remain poorly understood. In this study, we employed comprehensive proteomics and transcriptomics analysis to investigate the systemic and organ-specific adaptations to IF in male C57BL/6 mice. Following a 16 hr daily fa...
Ultra-mild bisulphite sequencing for DNA methylation analysis from low-input clinical specimens.
Ram Abou Zaki; Ishant Khurana; Assam El-Osta
CLINICAL EPIGENETICS - 16 Apr 2026
In a recent paper published in Nature Communications, Dai and colleagues offer a practical re-engineering of a workhorse: ultra-mild bisulphite sequencing (UMBS-seq), which re-tunes classical bisulphite conversion so that fragmented, low-input clinical DNA can yield methylomes that are not merely usable, but technically reliable. In this commentary, we set the advance in its proper frame-less a...
Waist-to-Height Ratio Is Associated With the Risk of Coronary Artery Disease in Type 1 Diabetes: A 19-Year Cohort Study.
Erika Bezerra Parente; Fanny Jansson Sigfrids; Per-Henrik Groop; Lena M Thorn; Niina Sandholm; Valma Harjutsalo;
DIABETES CARE - 14 Apr 2026
Obesity, kidney disease, and coronary artery disease (CAD) are interconnected. Here, the relationship between central obesity and CAD across albuminuria categories in type 1 diabetes was investigated. Data on 4,349 individuals without prior CAD from the Finnish Diabetic Nephropathy Study were analyzed. Central obesity was defined as waist-to-height ratio (WHtR) ≥0.5. Outcomes included acute myo...
Exercise effects on lean body mass, muscle strength and functional performance in patients with metastatic breast cancer: the randomized controlled PREFERABLE-EFFECT study.
Eva M Zopf; Gustav Joernaker; Dorothea Clauss; Mark Trevaskis; Anouk E Hiensch; Martina E Schmidt; Evelyn M Monninkhof; Philipp Zimmer; Jon Belloso; Elisa Heyrman; Rodrigo Fernandez Gonzalo; Joachim Wiskemann; Jana Müller; Kate A Bolam; Maciej Gorecki; Renske Altena; Christine Muttiah; Elsken van der Wall; Neil K Aaronson; Elzbieta Senkus; Ander Urruticoechea; Martijn M Stuiver; Karen Steindorf; Wilhelm Bloch; Yvonne Wengström; Anne M May; Helene Rundqvist
BREAST CANCER RESEARCH : BCR - 13 Apr 2026
Beyond CABG vs. PCI: Contemporary and Future Coronary Revascularisation from Historical Evolution to Artificial Intelligence, Robotics, and Hybrid Strategies.
Justin Ren; Christopher M Reid; Dion Stub; William Chan; Colin Royse; Jason E Bloom; Garry W Hamilton; Liam Munir; Gihwan Song; Daksh Tyagi; Joshua G Kovoor; Aashray Gupta; Nilesh Srivastav; Alistair Royse
JOURNAL OF CLINICAL MEDICINE - 01 Apr 2026
Coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) are the two dominant revascularisation strategies for obstructive coronary artery disease, yet their relative roles continue to shift because they address coronary pathophysiology differently with ever-evolving techniques. PCI has advanced through iterative improvements, including balloon angioplasty, bare-metal...
Current evidence for diagnosis and management of cardiac vasculitis.
Shaun Khanna; Aditya Bhat; Liza Thomas; Clare Arnott; Nitesh Nerlekar
HEART (BRITISH CARDIAC SOCIETY) - 20 Apr 2026
Cardiac vasculitis represents a heterogeneous group of immune-mediated disorders that can involve the coronary vessels, myocardium, valvular apparatus and pericardial tissues. Despite its rarity, cardiac vasculitis may result in significant clinical sequelae such as acute coronary syndrome, heart failure, cardiac arrhythmias and pericarditis. Diagnosis is challenging because symptoms are often ...
Risk Prediction in Cardio-Oncology: Conceptual and Methodological Considerations: JACC: CardioOncology State-of-the-Art Review.
Jonathan Sen; Eitan Amir; Peter C Austin; Thomas H Marwick; Chris McIntosh; Paaladinesh Thavendiranathan; Husam Abdel-Qadir
JACC. CARDIOONCOLOGY - 01 Apr 2026
Risk prediction models can guide prevention, monitoring, and treatment decisions in cardio-oncology, but their development requires careful attention to methodological challenges unique to cardiovascular disease arising in the context of cancer. In this state-of-the-art review, the authors use case scenarios to illustrate how prediction objectives, index dates, and time horizons must align with...
Spatio-temporal targeting of cardiac cells with lipid nanoparticles after myocardial infarction.
Rebecca L Harper; Gabriella E Farrugia; Crisdion Krstevski; Nicola Alexander; Sebastien R Raffaut; Thomas Harrison; Anita Thomas; Helen Kiriazis; Akshima Dogra; Mark Louis P Vidallon; Xiaowei Wang; Hojin Chang; Daniel G Donner; Patrick M Lelliott; Alexander R Pinto
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY PLUS - 01 Jun 2026
Ischemic heart disease remains the leading cause of morbidity and mortality worldwide. While current therapies prolong survival, they do not address underlying tissue damage. Messenger RNA (mRNA)-based therapies offer a promising alternative for repair and regeneration. However, targeted and effective delivery to the injured heart remains challenging. Lipid nanoparticles (LNPs) have emerged as ...
Artificial intelligence-powered virtual standardized patients in teaching history-taking skills to medical students: a randomized controlled trial.
Hai Nguyen Ngoc Dang; Thang Viet Luong; Hoa Thi Ha Vo; Linh Thi Khanh Nguyen; Trung Nguyen Tran; Hong Thi Anh Pham; Huong Thanh Truong; Hoa Tran; Toan Thanh Tran; Tien Anh Hoang; Thang Chi Doan; Quan Huynh; Thomas H Marwick
BMC MEDICAL EDUCATION - 30 Apr 2026
Correction: Alpha-7 nicotinic acetylcholine receptor: targeting the interplay between inflammation, renin-angiotensin aldosterone system, and nervous system for the novel treatment of heart failure.
Jordan Swiderski; Laura Kate Gadanec; Stephen Hearth; Benjamin Darcy Rowlands; Andrew James Murphy; Vasso Apostolopoulos; Anthony Zulli
FRONTIERS IN PHARMACOLOGY - 01 Jan 2026
[This corrects the article DOI: 10.3389/fphar.2026.1756039.].
Prothrombotic genetic variants and cancer-associated venous thromboembolism: defining thrombotic risk across tumor types.
Hannah Stevens; William W H Ho; Manika Singh; Rodrigo Canovas; Ruidong Xiang; Huyen Tran; Fumihiko Takeuchi; Karlheinz Peter; James D McFadyen
HAEMATOLOGICA - 07 May 2026
Cancer-associated venous thromboembolism (CAT) is a major cause of mortality in cancer patients. Prothrombotic genetic variants increase venous thromboembolism risk in the general population, but contribution to CAT remains unclear, particularly within different tumor types. We sought to determine whether the presence of thrombophilic variants influence relative and absolute CAT risk, and may b...
LIPID MAPS: Powering discovery in lipidomics.
Lauren Cockayne; Matthew J Conroy; Chetin Baloglu; Eoin Fahy; Gerhard Hagn; Oswald Quehenberger; Aaron M Armando; Gabriele Lombardi Bendoula; Jean-Marie Galano; Ángel Sánchez-Illana; Thierry Durand; Nadja Kampschulte; Paul D Kennedy; Miguel Gijón; Hiroshi Tsugawa; Makoto Arita; Kirk Maxey; Meghan Truskowski; Ondrej Kuda; Shazia Khan; Natalie Z M Homer; Yuki Matsuzawa; Rosario Domingues; Peter J Meikle; Corey Giles; Kevin Huynh; Robert C Murphy; Zidan Wang; Yu Xia; Xue Li Guan; Kim Ekroos; Gerhard Liebisch; Alfred H Merrill; Andrea F Lopez-Clavijo; Dominic Campopiano; Craig E Wheelock; Shankar Subramaniam; Robert Andrews; Laura Goracci; Zhixu Ni; Maria Fedorova; Simon Andrews; William Griffiths; Ruth Andrew; Edward A Dennis; Valerie B O'Donnell
SCIENCE SIGNALING - 05 May 2026
As lipidomics approaches its 25th anniversary, we explore how lipid research has matured over the years while highlighting emerging innovations that are expanding our ability to study these diverse, life-critical biomolecules. In particular, we showcase the community-driven, open-access databases, software, and educational resources made freely available through the ELIXIR Core Data Resource LI...
Unlocking the potential of light-intensity physical activity for public health: a call to action for research.
Stephanie A Prince; Jean-Philippe Chaput; Rachel C Colley; Paddy C Dempsey; Ulf Ekelund; Ian Janssen; Justin J Lang; Emmanuel Stamatakis; Jakob Tarp; Mark S Tremblay; Marisol T Betancourt; Gregory P Butler; Karen C Roberts
BRITISH JOURNAL OF SPORTS MEDICINE - 04 May 2026
Show more...